Show Summary Details
Page of

Juvenile idiopathic arthritis 

Juvenile idiopathic arthritis
Juvenile idiopathic arthritis
Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 31 May 2020

Juvenile idiopathic arthritis: overview 352

Oligoarticular juvenile idiopathic arthritis 358

Rheumatoid factor (RF) negative polyarticular JIA 359

Rheumatoid factor (RF) positive polyarticular JIA 360

Systemic onset JIA 362

Juvenile PsA 364

Long-term studies have shown that juvenile idiopathic arthritis (JIA) is not as benign as previously thought, with approximately 50% of adults suffering from persistent inflammation and disability (Packham, 2002). There has been a shift towards early aggressive treatment to limit inflammation and achieve a normal lifestyle, since there is some evidence for a better long-term prognosis with this approach. The development of drugs such as the anti-cytokine agents for disease resistant to conventional treatment has greatly improved disease management....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.